TNR Still's Now Journal Club - Pivotal Trials in SJIA & AOSD Approved Meds

Jul 27, 2022 7:54 am
This week's Stills disease Journal Club features expert discussants Drs. Olga Petryna, Daniel Lovell, Hermine Brunner and Jack Cush. Journal articles reviewed includes: - CONSIDER Trial. Canakinumab for Treatment of Adult-Onset Still's Disease. Kedor C. Ann Rheum Dis 2020 Aug;79:1090-1097 https://bit.ly/3coPFg0 - TENDER Trial. Tocilizumab in systemic juvenile idiopathic arthritis. De Benedetti F. N Engl J Med. 2012 Dec 20;367:2385-95 https://bit.ly/3uXFq8Q

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Subscribe and Rate

Subscribe to the RheumNow podcast on your favorite podcast app to get automatic downloads of the latest content. Listen in the car, airplane, anywhere! We also reach more listeners through reviews from our users. Consider leaving a review!
 

 

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2023 All Rights Reserved.

×